Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topotecan and Carboplatin for Platinum-Sensitive Relapsed Ovarian Cancer
NCT00316173Phase 2Completed
- Sponsor
- GSK
- Start
- Mar 2005
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of topotecan in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by GSK. Started Mar 2005; status: completed.
02
Drugs
topotecan
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT00316173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00316173.